At this year’s ISMPP conference, we’re speaking from the heart. Our ‘We Love Pubs’ booth theme has been designed to reflect ...

AstraZeneca (AZ) and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) has been approved by the US Food and Drug ...

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

Gilead Sciences’ Livdelzi (seladelpar) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adults with the rare liver disease primary biliary cholangitis (PBC) ...

Exciting news for Innovative Trials! We’re delighted to welcome John Watkinson MBE as our first Non-Executive Chair. John’s ...

Discover the key takeaways from OPEN Health’s latest whitepaper: "The Potential Impact of the New Presidential Administration ...

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our planet. But are those connections working for or against your… ...

Prescribing support services PSS is one of the largest nhs medicines management providers in the UK. We work with a range of partners to deliver practice /ccg wide disease management proggrammes This ...

AstraZeneca’s (AZ) Calquence (acalabrutinib) has been approved by the US Food and Drug Administration (FDA) as part of a ...

Funded by Prostate Cancer UK, the ICR team focused on genes involved in the PI3K-AKT pathway, which is frequently mutated in ...

Lumakras (sotorasib) and Vectibix (panitumumab) have been authorised for use in adults with KRAS G12C-mutated metastatic ...

The 39th PM Society Awards will take place on Friday 14 March 2025, supported by Avalere Health. This is the longest running ...